Newborn Screening Laboratory
TN Newborn Screening Performance Indicators Dashboard
NBS Fee Increase Notice to Tennessee Birthing Hospitals (effective 1-1-2020)
NBS Fee Increase Commissioner Approval (8/2/2019)
The Newborn Screening Laboratory recieves samples and performs testing seven days per week.
Monday - Friday: 8:00 a.m. - 4:30 p.m.
Saturday - Sunday: 7:00 a.m. - 3:30 p.m.
This video is provided as an example of an approved blood collection procedure. While the State of Tennessee currently does business with PerkinElmer, Inc., the posting of this video is not an endorsement of the company.
The Tennessee Newborn Screening (NBS) Laboratory tests over 80,000 specimens each year. Tennessee Code Annotated Title 68, Chapter 5, Part 4 requires that all infants born in Tennessee receive screening for certain conditions. Laboratory tests are done to help find infants who may have one of the disorders or medical conditions.
Finding and treating these disorders early can prevent serious complications such as growth problems, developmental delays, deafness, blindness, intellectual disabilities, seizures, and sudden or early death.
The newborn screening tests require a simple heel stick blood sample collected from newborns between 24-36 hours after birth. If the screening result for one of the laboratory tests is outside of the expected range, the program's Newborn Screening Follow-up nurses will immediately begin follow-up. This often includes contacting the infant’s physician to initiate a repeat screen, confirmation of a diagnosis, and treatment from a specialist if necessary.
Newborn Screening Follow-up, housed in the Division of Family Health and Wellness, also provides parent resources and educational and training resources for providers.
- Carbamoyl Phosphate Synthetase I Deficiency (CPS I)
- Carnitine Acylcarnitine Translocase Deficiency (CACTD)
- Carnitine Palmitoyltransferase Type I Deficiency (CPT I)
- Carnitine Palmitoyltransferase Type II Deficiency (CPTII)
- Carnitine Uptake Defect (CUD)
- Citrullinemia Type I (CIT)
- Citrullinemia Type II (CIT II)
- Congenital Adrendal Hyperplasia I (CAH)
- Congenital Hypothyroidism (CH)
- Cystic Fibrosis (CF)